O'Kell Allison L, Grant David C, Panciera David L, Troy Gregory C, Weinstein Nicole M
Department of Small Animal Clinical Sciences, Virginia-Maryland Regional College of Veterinary Medicine, Virginia Polytechnic Institute and State University, Blacksburg, VA 24061, USA.
Am J Vet Res. 2012 Oct;73(10):1569-76. doi: 10.2460/ajvr.73.10.1569.
To determine the effects of oral prednisone administration with or without ultralow-dose acetylsalicylic acid on coagulation parameters in healthy dogs and to assess intraindividual variation in thromboelastography results.
14 healthy research dogs and 10 healthy client-owned dogs.
In a randomized controlled trial, research dogs underwent thromboelastography twice (3 days apart), and intraindividual variation in test results was calculated. Dogs were given prednisone (2 mg/kg/d, PO) plus acetylsalicylic acid (0.5 mg/kg/d, PO) or prednisone (2 mg/kg/d, PO) plus a placebo for 14 days, after which thromboelastography and other tests were repeated. Differences from preadministration (baseline) test results between and within groups were compared. In a separate trial, client-owned dogs also underwent thromboelastography twice 2 days apart to assess intraindividual variation in untreated dogs.
Intraindividual variation in thromboelastography results for research dogs was ≤ 10% for maximum amplitude (MA) and α angle. In the research dogs, MA and fibrinogen values significantly increased from baseline, whereas percentage lysis 30 minutes after attainment of the MA as well as antithrombin activity significantly decreased within each group. In the dogs that received prednisone plus a placebo, percentage lysis 60 minutes after attainment of the MA was significantly lower than at baseline. For all parameters for research dogs, there was no difference between groups for change from baseline. Intraindividual variation in findings for client-owned dogs was similar to the variation for research dogs.
Prednisone administration resulted in hypercoagulability in healthy dogs as indicated by an increase in MA and plasma fibrinogen concentration and a decrease in antithrombin activity. Concurrent ultralow-dose acetylsalicylic acid use had no effect on measured thromboelastography values. The high intraindividual variation in some thromboelastography parameters may preclude routine use of this technique in clinical practice.
确定口服泼尼松联合或不联合超小剂量乙酰水杨酸对健康犬凝血参数的影响,并评估血栓弹力图结果的个体内差异。
14只健康的实验犬和10只健康的客户拥有的犬。
在一项随机对照试验中,实验犬接受两次血栓弹力图检查(间隔3天),并计算测试结果的个体内差异。犬接受泼尼松(2mg/kg/d,口服)加乙酰水杨酸(0.5mg/kg/d,口服)或泼尼松(2mg/kg/d,口服)加安慰剂,持续14天,之后重复进行血栓弹力图检查和其他测试。比较组间和组内给药前(基线)测试结果的差异。在另一项试验中,客户拥有的犬也间隔2天接受两次血栓弹力图检查,以评估未治疗犬的个体内差异。
实验犬血栓弹力图结果中,最大振幅(MA)和α角的个体内差异≤10%。在实验犬中,MA和纤维蛋白原值较基线显著升高,而每组中达到MA后30分钟的溶解百分比以及抗凝血酶活性显著降低。在接受泼尼松加安慰剂的犬中,达到MA后60分钟的溶解百分比显著低于基线。对于实验犬的所有参数,组间与基线相比的变化无差异。客户拥有的犬的检查结果个体内差异与实验犬相似。
泼尼松给药导致健康犬出现高凝状态,表现为MA和血浆纤维蛋白原浓度升高以及抗凝血酶活性降低。同时使用超小剂量乙酰水杨酸对测得的血栓弹力图值无影响。一些血栓弹力图参数的高个体内差异可能使该技术无法在临床实践中常规使用。